Liver Cancer Trial, Recruiting (NCT06208397)

Liver Cancer Trial, Recruiting NCT06208397 Sponsor: Shengjing Hospital Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06208397 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with colorectal cancer that has spread to the liver (known as colorectal liver metastases)
People who have had surgery, with tissue samples taken and examined in a laboratory to confirm their diagnosis
People who have no medical reasons preventing them from having an MRI (magnetic resonance imaging) scan

Who may not be able to join:

People whose MRI scan images are not clear enough to be measured accurately
People whose liver tumours are smaller than 1 centimetre in size
People who also have serious problems with other major organs in their body
People who have been diagnosed with another type of cancer
People who do not sign the consent form agreeing to take part in the trial
People who have metal objects inside their body, such as a pacemaker, artificial metal heart valve, metal joint, metal implant, or items that cannot be removed such as certain dentures, insulin pumps, or contraceptive rings (as these can be unsafe in an MRI scanner)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yu Shi, M.D., Shengjing Hospital

Phone: 18940259980

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06208397

Sponsor: Shengjing Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 18940259980

More information: https://clinicaltrials.gov/study/NCT06208397

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with colorectal cancer that has spread to the liver (known as colorectal liver metastases)
People who have had surgery, with tissue samples taken and examined in a laboratory to confirm their diagnosis
People who have no medical reasons preventing them from having an MRI (magnetic resonance imaging) scan

Who may not be able to join:

People whose MRI scan images are not clear enough to be measured accurately
People whose liver tumours are smaller than 1 centimetre in size
People who also have serious problems with other major organs in their body
People who have been diagnosed with another type of cancer
People who do not sign the consent form agreeing to take part in the trial
People who have metal objects inside their body, such as a pacemaker, artificial metal heart valve, metal joint, metal implant, or items that cannot be removed such as certain dentures, insulin pumps, or contraceptive rings (as these can be unsafe in an MRI scanner)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Shengjing Hospital

Registry

ClinicalTrials.gov

Start date

24 December 2023

Est. completion

24 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Radiological assessment of CRLM

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov